Supernus Pharmaceuticals, Inc.
2013 Q4 - 2025 Q4 (27 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 2,651 | 0.0% | 53,339 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 2,552 | 0.0% | 53,407 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 1,603 | 0.0% | 50,866 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 1,666 | 0.0% | 50,866 | 3/31/2025 |
| 2024 Q4 | 3/18/2025 | 1,850 | 0.0% | 51,149 | 12/31/2024 |
| 2024 Q3 | 4/4/2025 | 1,610 | 0.0% | 51,648 | 9/30/2024 |
| 2024 Q2 | 4/8/2025 | 1,432 | 0.0% | 53,515 | 6/30/2024 |
| 2024 Q1 | 5/16/2024 | 1,846 | 0.0% | 54,113 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 1,642 | 0.0% | 56,723 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 1,627 | 0.0% | 59,013 | 9/30/2023 |
| 2023 Q2 | 8/21/2023 | 1,930 | 0.0% | 64,199 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 2,389 | 0.0% | 65,945 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 2,367 | 0.0% | 66,353 | 12/31/2022 |
| 2022 Q3 | 11/21/2022 | 2,211 | 0.0% | 65,313 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 1,926 | 0.0% | 66,590 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 2,147 | 0.0% | 66,433 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 2,096 | 0.0% | 71,871 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 1,863 | 0.0% | 69,837 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 2,088 | 0.0% | 67,799 | 6/30/2021 |
| 2021 Q1 | 5/18/2021 | 1,926 | 0.0% | 73,562 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 1,860 | 0.0% | 73,940 | 12/31/2020 |
| 2020 Q3 | 11/17/2020 | 1,533 | 0.0% | 73,553 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 1,747 | 0.0% | 73,553 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 1,340 | 0.0% | 74,479 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 1,787 | 0.0% | 75,320 | 12/31/2019 |
| 2014 Q1 | 5/8/2014 | 329 | 0.0% | 36,745 | 3/31/2014 |
| 2013 Q4 | 2/10/2014 | 222 | 0.0% | 29,445 | 12/31/2013 |